Laddar...
Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats
OBJECTIVE: To seek efficient aldose reductase inhibitors (ARIs) with excellent in vitro and in vivo biological activities against rat galactosemic cataract. METHODS: The method was firstly optimized to screen strong ARIs from nonoriented synthetic compounds and natural extracts. Then, diosgenin was...
Sparad:
| I publikationen: | J Diabetes Res |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Hindawi
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5605930/ https://ncbi.nlm.nih.gov/pubmed/29038789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7309816 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|